536
Views
27
CrossRef citations to date
0
Altmetric
Review

Systemic therapy for the treatment of endometrial cancer

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2019-2032 | Received 23 Feb 2019, Accepted 08 Aug 2019, Published online: 26 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yuwei Li, Ziling Yang, Mengyao Zeng, Ying Wang, Xin Chen, Shibo Li, Xiaotong Zhao & Yuhui Sun. (2023) Circular RNA differential expression profiles and bioinformatics analysis of hsa_circRNA_079422 in human endometrial carcinoma. Journal of Obstetrics and Gynaecology 43:2.
Read now
Keishi Akada, Noriyuki Koyama, Takuma Miura, Eiji Fukunaga, Yuji Miura, Ken Aoshima & Keiichi Fujiwara. (2021) Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan. Current Medical Research and Opinion 37:7, pages 1171-1178.
Read now

Articles from other publishers (25)

Chase William Morrison, Kayvon Nick Sanjasaz, Saul David Nathanson, Supriya Raina-Hukku, David Matthew Pinkney & Alexis Anna Davenport. (2023) Dedifferentiated endometrial carcinoma metastasis to axillary lymph node: a case report. Journal of Medical Case Reports 17:1.
Crossref
Jessica Satei, Ariana N Afrakhteh & Kim Abbegail T Aldecoa. (2023) Endometrial Adenocarcinoma in Young Women: A Case Report and Review of Literature. Cureus.
Crossref
Sidra Khan, Noor A. Lokman, Martin K. Oehler, Carmela Ricciardelli & Andrea J. Yool. (2023) Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels. Cancers 15:18, pages 4507.
Crossref
A. Yu. Goryainova, M. G. Leonov, R. A. Murashko, O. S. Tsirulnikova & O. Yu. Chukhrai. (2023) Organization clinical decision-making programs in the local practice of the region: problematic issues that determine the choice of therapy in the progression of endometrial cancer. Meditsinskiy sovet = Medical Council:11, pages 142-149.
Crossref
Wan Shu, Ziwei Wang, Wei Zhang, Jun Zhang, Rong Zhao, Zhicheng Yu, Kejun Dong & Hongbo Wang. (2023) Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer. Combinatorial Chemistry & High Throughput Screening 26:8, pages 1488-1502.
Crossref
Wenwen Zhang, Meihua Liu, Yurou Ji, Dake Yu, Chuanrui Ma, Jianguo Zhao & Pengpeng Qu. (2023) Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway. Archives of Biochemistry and Biophysics 743, pages 109655.
Crossref
Wenxue Li, Yujing Qin, Xiujuan Chen & Xiaolei Wang. (2023) Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancer: A field synopsis of observational study. Medicine 102:25, pages e34047.
Crossref
Rohit R Doke, Aditi R Lende, Shweta S Mule, Mrunal S Mahajan, Pranali Kulawade, Gayatri V Korde & Rutuja B Bhand. (2023) Endometrial cancer: Pathophysiology, diagnosis and management. IP International Journal of Comprehensive and Advanced Pharmacology 8:2, pages 80-85.
Crossref
Kang He, Jingze Li, Xuemiao Huang, Weixin Zhao, Kai Wang, Taiwei Wang, Junyu Chen, Zeyu Wang, Jiang Yi, Shuhua Zhao & Lijing Zhao. (2023) KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. Frontiers in Oncology 13.
Crossref
Bingfeng Lu, Xi Chen, Xin Liu, Jingwen Chen, Honglei Qin, Shuo Chen & Yang Zhao. (2022) C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1. Journal of Translational Medicine 20:1.
Crossref
Akiko Yamamoto, Takeo Nagashima, Yoshinari Imai, Kensuke Akitsu, Zenta Yamanaka & Hirotaka Nishi. (2022) A case of recurrent endometrial cancer with long‐term complete remission following pembrolizumab‐induced severe i mmune‐related adverse event colitis . Journal of Obstetrics and Gynaecology Research 48:10, pages 2630-2634.
Crossref
Bartłomiej Barczyński, Karolina Frąszczak, Iwona Wertel, Ewelina Zakrzewska, Małgorzata Zdunek, Justyna Szumiło & Jan Kotarski. (2022) Immunohistochemical Expression of LHRH Receptor in Different Compartments of Female Genital Tract in Patients With Endometrial Cancer. Applied Immunohistochemistry & Molecular Morphology 30:7, pages 509-516.
Crossref
Xiaojuan Li & Yahong Liu. (2022) Hsa_circ_0000437 Inhibits the Development of Endometrial Carcinoma through miR-626/CDKN1B Axis. Protein & Peptide Letters 29:7, pages 611-620.
Crossref
Beatriz Villafranca-Magdalena, Carina Masferrer-Ferragutcasas, Carlos Lopez-Gil, Eva Coll-de la Rubia, Marta Rebull, Genis Parra, Ángel García, Armando Reques, Silvia Cabrera, Eva Colas, Antonio Gil-Moreno & Cristian P. Moiola. (2022) Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool. International Journal of Molecular Sciences 23:11, pages 6266.
Crossref
Cristina Martín-Sabroso, Irene Lozza, Ana Isabel Torres-Suárez & Ana Isabel Fraguas-Sánchez. (2021) Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics 13:10, pages 1705.
Crossref
M Abtahi, S Gholami & H H Jassim. (2021) High dose rate 192 Ir versus high dose rate 60 Co brachytherapy: an overview of systematic reviews of clinical responses of gynecological cancers from 1984 to 2020 . Biomedical Physics & Engineering Express 7:5, pages 055022.
Crossref
Yanqi Dong, Aiqi Yin, Caiqu Xu, Huiping Jiang, Qinghai Wang, Wenjuan Wu & Suiqun Guo. (2021) OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression. Oncology Letters 22:2.
Crossref
Jian Ma, Fan-Fei Kong, Di Yang, Hui Yang, Cuicui Wang, Rong Cong & Xiao-Xin Ma. (2021) lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway. Molecular Therapy - Nucleic Acids 24, pages 905-922.
Crossref
Nina Kovacevic. (2021) Surgical treatment and fertility perservation in endometrial cancer. Radiology and Oncology 55:2, pages 144-149.
Crossref
Valerio Mais & Michele Peiretti. (2021) Immunohistochemical Markers in Endometrial Cancer. Cancers 13:3, pages 505.
Crossref
Sebastjan Merlo, Gregor Vivod, Sonja Bebar, Maša Bošnjak, Maja Čemažar, Gregor Serša, Simona Kranjc Brezar & Nina Kovačević. (2021) Literature Review and Our Experience With Bleomycin-Based Electrochemotherapy for Cutaneous Vulvar Metastases From Endometrial Cancer. Technology in Cancer Research & Treatment 20, pages 153303382110101.
Crossref
Jian Ma, Jing-Kai Zhang, Di Yang & Xiao-Xin Ma. (2020) Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment. Aging 12:21, pages 22152-22173.
Crossref
Yusuke Toyohara, Kenbun Sone, Haruka Nishida, Ayumi Taguchi, Yuichiro Miyamoto, Michihiro Tanikawa, Mayuyo Mori, Tetsushi Tsuruga, Yoko Matsumoto, Katsutoshi Oda, Yutaka Osuga & Tomoyuki Fujii. (2020) Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer. Journal of Obstetrics and Gynaecology Research 46:11, pages 2298-2304.
Crossref
Ling Liu, Zhi‐Ying Yu, Tan‐Tan Yu, Shi‐Hong Cui, Li Yang, Hui Chang, Yan‐Hong Qu, Xiao‐Feng Lv, Xiao‐An Zhang & Chen‐Chen Ren. (2020) A Slug‐dependent mechanism is responsible for tumor suppression of p53‐stabilizing compound CP‐31398 in p53‐mutated endometrial carcinoma. Journal of Cellular Physiology 235:11, pages 8768-8778.
Crossref
Liyan Xu, Yafen Qiu, Ling Feng, Li Zhou, Xufeng Chen & Dongqi Yu. (2020) Correlation between single nucleotide polymorphisms of DACH1 gene microRNA binding site and susceptibility of patients with endometrial cancer. Medicine 99:25, pages e20793.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.